Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.

Yujie DengXiaohui ChenChuanzhong HuangJun SongSisi FengXuzheng ChenRuixiang Zhou

Published in: Journal of oncology (2022)

The DEGs can probably be used as potential predictors for stage-I LUAD worse prognosis and UBE2T may be a potential tumor promoter and target for treatment.

Keyphrases

poor prognosis
long non coding rna
dna methylation
genome wide
gene expression
neoadjuvant chemotherapy
transcription factor
squamous cell carcinoma
risk assessment
climate change